Skip to main content

Vaneck Pharmaceutical ETF(PPH-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time


Fund Family
Underlying Index
Inception Date


The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals. Expenses for PPH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

Investment Information

Managed Assets, $K
Shares Outstanding, K
Asset Class
ETFs - Healthcare
60-Month Beta
Net Asset Value
Management Fee
Most Recent Dividend
Last Dividend Date
Dividend Yield
Has Options
20-Day Average Volume
52-Week RangeLow price74.05-High price91.16
YTD Return %
1-Year %Chg
3-Year %Chg
5-Year %Chg